Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Scope Of Study
2.5. Crisis Scenario Analysis
2.6. Major Market Findings
2.6.1. Branded Drugs Are The Most Commonly Used Products In The Pharmaceutical Logistics Market
2.6.2. Communicable Diseases Hold The Largest Market Share In The Therapy Area
2.6.3. Cold Chain Logistics Is The Fastest-Growing Type Within The Pharmaceutical Logistics Market
2.6.4. Monitoring Of Pharmaceutical Logistics Operations Is Increasingly Becoming A Focus Area

3. Market Dynamics
3.1. Key Drivers
3.1.1. Rising Need For Temperature-Controlled Solutions In Pharmaceuticals
3.1.2. Expansion Of Ocean Freight Services In Pharmaceutical Industry
3.1.3. Rise In Consumer Preference For Over-The-Counter Medicines
3.1.4. Surge In Pharmaceutical Logistics During The United States Covid-19 Pandemic
3.2. Key Restraints
3.2.1. Rigorous Regulatory Requirements In Pharmaceutical Logistics
3.2.2. Ensuring Real-Time Transparency And Reliability In Pharmaceutical Logistics

4. Key Analytics
4.1. Key Market Trends
4.1.1. Surge In Demand For Cell & Gene Therapy Logistics
4.1.2. Revolutionizing Pharmaceutical Logistics Through Digital Transformation
4.1.3. Increasing Clinical Trials Logistics Demands
4.2. Porter’S Five Forces Analysis
4.2.1. Buyers Power
4.2.2. Suppliers Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Growth Prospect Mapping
4.3.1. Growth Prospect Mapping For United States
4.4. Market Concentration Analysis
4.5. Value Chain Analysis
4.5.1. Manufacturing
4.5.2. Storage
4.5.3. Transportation
4.5.4. Distribution
4.5.5. Monitoring Components
4.5.6. Consumption
4.6. Key Buying Criteria
4.6.1. Type Of Logistics
4.6.2. Services Offered
4.6.3. Mode Of Transportation
4.6.4. Application
4.6.5. Regulatory Compliance
4.6.6. Technological Capabilities
4.6.7. Cost
4.6.8. Reliability
4.6.9. Agility

5. Market By Product
5.1. Branded Drugs
5.1.1. Market Forecast Figure
5.1.2. Segment Analysis
5.2. Generic Drugs
5.2.1. Market Forecast Figure
5.2.2. Segment Analysis
5.3. Otc
5.3.1. Market Forecast Figure
5.3.2. Segment Analysis

6. Market By Therapy Area
6.1. Communicable Diseases
6.1.1. Market Forecast Figure
6.1.2. Segment Analysis
6.2. Oncology
6.2.1. Market Forecast Figure
6.2.2. Segment Analysis
6.3. Diabetes
6.3.1. Market Forecast Figure
6.3.2. Segment Analysis
6.4. Cardiovascular Diseases
6.4.1. Market Forecast Figure
6.4.2. Segment Analysis
6.5. Autoimmune Diseases
6.5.1. Market Forecast Figure
6.5.2. Segment Analysis
6.6. Neurological Disorders
6.6.1. Market Forecast Figure
6.6.2. Segment Analysis
6.7. Pain Management
6.7.1. Market Forecast Figure
6.7.2. Segment Analysis
6.8. Respiratory Diseases
6.8.1. Market Forecast Figure
6.8.2. Segment Analysis
6.9. Other Therapy Areas
6.9.1. Market Forecast Figure
6.9.2. Segment Analysis

7. Market By Type
7.1. Non-Cold Chain Logistics
7.1.1. Market Forecast Figure
7.1.2. Segment Analysis
7.2. Cold Chain Logistics
7.2.1. Market Forecast Figure
7.2.2. Segment Analysis

8. Market By Component
8.1. Storage
8.1.1. Warehouse
8.1.1.1. Market Forecast Figure
8.1.1.2. Segment Analysis
8.1.2. Refrigerated Containers
8.1.2.1. Market Forecast Figure
8.1.2.2. Segment Analysis
8.2. Transportation
8.2.1. Overland Logistics
8.2.1.1. Market Forecast Figure
8.2.1.2. Segment Analysis
8.2.2. Sea Freight Logistics
8.2.2.1. Market Forecast Figure
8.2.2.2. Segment Analysis
8.2.3. Air Freight Logistics
8.2.3.1. Market Forecast Figure
8.2.3.2. Segment Analysis
8.3. Monitoring Components
8.3.1. Hardware
8.3.1.1. Sensors
8.3.1.1.1. Market Forecast Figure
8.3.1.1.2. Segment Analysis
8.3.1.2. Rfid Devices
8.3.1.2.1. Market Forecast Figure
8.3.1.2.2. Segment Analysis
8.3.1.3. Telematics
8.3.1.3.1. Market Forecast Figure
8.3.1.3.2. Segment Analysis
8.3.1.4. Networking Devices
8.3.1.4.1. Market Forecast Figure
8.3.1.4.2. Segment Analysis
8.3.2. Software
8.3.2.1. Market Forecast Figure
8.3.2.2. Segment Analysis

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Agility Logistics
9.2.1.1. Company Overview
9.2.1.2. Product Portfolio
9.2.1.3. Strengths & Challenges
9.2.2. Ap Moller - Maersk
9.2.2.1. Company Overview
9.2.2.2. Product Portfolio
9.2.2.3. Strengths & Challenges
9.2.3. Cardinal Health
9.2.3.1. Company Overview
9.2.3.2. Product Portfolio
9.2.3.3. Strengths & Challenges
9.2.4. Cencora (Amerisourcebergen)
9.2.4.1. Company Overview
9.2.4.2. Product Portfolio
9.2.4.3. Strengths & Challenges
9.2.5. Ceva Logistics
9.2.5.1. Company Overview
9.2.5.2. Product Portfolio
9.2.5.3. Strengths & Challenges
9.2.6. Db Schenker
9.2.6.1. Company Overview
9.2.6.2. Product Portfolio
9.2.6.3. Strengths & Challenges
9.2.7. Deutsche Post Ag
9.2.7.1. Company Overview
9.2.7.2. Product Portfolio
9.2.7.3. Strengths & Challenges
9.2.8. Dsv
9.2.8.1. Company Overview
9.2.8.2. Product Portfolio
9.2.8.3. Strengths & Challenges
9.2.9. Fedex
9.2.9.1. Company Overview
9.2.9.2. Product Portfolio
9.2.9.3. Strengths & Challenges
9.2.10. Kuehne + Nagel
9.2.10.1. Company Overview
9.2.10.2. Product Portfolio
9.2.10.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping For United States
Figure 4: Market Concentration Analysis
Figure 5: Value Chain Analysis
Figure 6: Key Buying Criteria
Figure 7: United States Pharmaceutical Logistics Market, Growth Potential, By Product, In 2023
Figure 8: United States Pharmaceutical Logistics Market, By Branded Drugs, 2024-2032 (In $ Million)
Figure 9: United States Pharmaceutical Logistics Market, By Generic Drugs, 2024-2032 (In $ Million)
Figure 10: United States Pharmaceutical Logistics Market, By Otc, 2024-2032 (In $ Million)
Figure 11: United States Pharmaceutical Logistics Market, Growth Potential, By Therapy Area, In 2023
Figure 12: United States Pharmaceutical Logistics Market, By Communicable Diseases, 2024-2032 (In $ Million)
Figure 13: United States Pharmaceutical Logistics Market, By Oncology, 2024-2032 (In $ Million)
Figure 14: United States Pharmaceutical Logistics Market, By Diabetes, 2024-2032 (In $ Million)
Figure 15: United States Pharmaceutical Logistics Market, By Cardiovascular Diseases, 2024-2032 (In $ Million)
Figure 16: United States Pharmaceutical Logistics Market, By Autoimmune Diseases, 2024-2032 (In $ Million)
Figure 17: United States Pharmaceutical Logistics Market, By Neurological Disorders, 2024-2032 (In $ Million)
Figure 18: United States Pharmaceutical Logistics Market, By Pain Management, 2024-2032 (In $ Million)
Figure 19: United States Pharmaceutical Logistics Market, By Respiratory Diseases, 2024-2032 (In $ Million)
Figure 20: United States Pharmaceutical Logistics Market, By Other Therapy Areas, 2024-2032 (In $ Million)
Figure 21: United States Pharmaceutical Logistics Market, Growth Potential, By Type, In 2023
Figure 22: United States Pharmaceutical Logistics Market, By Non-Cold Chain Logistics, 2024-2032 (In $ Million)
Figure 23: United States Pharmaceutical Logistics Market, By Cold Chain Logistics, 2024-2032 (In $ Million)
Figure 24: United States Pharmaceutical Logistics Market, Growth Potential, By Component, In 2023
Figure 25: United States Pharmaceutical Logistics Market, By Storage, 2024-2032 (In $ Million)
Figure 26: United States Pharmaceutical Logistics Market, By Warehouse, 2024-2032 (In $ Million)
Figure 27: United States Pharmaceutical Logistics Market, By Refrigerated Containers, 2024-2032 (In $ Million)
Figure 28: United States Pharmaceutical Logistics Market, By Transportation, 2024-2032 (In $ Million)
Figure 29: United States Pharmaceutical Logistics Market, By Overland Logistics, 2024-2032 (In $ Million)
Figure 30: United States Pharmaceutical Logistics Market, By Sea Freight Logistics, 2024-2032 (In $ Million)
Figure 31: United States Pharmaceutical Logistics Market, By Air Freight Logistics, 2024-2032 (In $ Million)
Figure 32: United States Pharmaceutical Logistics Market, By Monitoring Components, 2024-2032 (In $ Million)
Figure 33: United States Pharmaceutical Logistics Market, By Hardware, 2024-2032 (In $ Million)
Figure 34: United States Pharmaceutical Logistics Market, By Sensors, 2024-2032 (In $ Million)
Figure 35: United States Pharmaceutical Logistics Market, By Rfid Devices, 2024-2032 (In $ Million)
Figure 36: United States Pharmaceutical Logistics Market, By Telematics, 2024-2032 (In $ Million)
Figure 37: United States Pharmaceutical Logistics Market, By Networking Devices, 2024-2032 (In $ Million)
Figure 38: United States Pharmaceutical Logistics Market, By Software, 2024-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL LOGISTICS
TABLE 2: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: UNITED STATES STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: UNITED STATES STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: UNITED STATES TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: UNITED STATES TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: UNITED STATES MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: UNITED STATES MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: UNITED STATES HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: UNITED STATES HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES